Pennsylvania-based pharmaceutical company Cencora today announced a $1 billion investment in its U.S. distribution network, including an expansion of its facility in Dothan.
The investment will also include a second national distribution center in Ohio and an expansion in California.
“Health care providers rely on us to provide efficient access to the medications their patients need, and we’re able to deliver on that promise because of the robust distribution infrastructure and operations we’ve built through decades of investment,” said Bob Mauch, president and CEO of Cencora. “This investment underscores our commitment to and role in building a resilient pharmaceutical supply chain and in ensuring patients across the United States have timely and reliable access to prescribed medications, where and when they need them.”
The Dothan expansion, expected to be completed by fall 2026, will increase the facility’s refrigerated storage capacity by 500% and its frozen storage capacity by 200%.
“We’re committed to delivering an industry-leading customer experience — and that starts with listening to our customers, anticipating their needs and making strategic investments to ensure we can provide the exceptional service they expect,” said Rich Tremonte, executive vice president and president, U.S. Pharmaceuticals and Animal Health at Cencora. “As demand continues to grow and more specialty pharmaceuticals reach the market, the investments we’re making today will strengthen our ability to support our customers’ current and future needs, enabling them to continue delivering high-quality patient care in their communities.”
